DK1100468T3 - Mikropartikler med adsorbent-overflader, fremgangsmåder til fremstilling af disse samt anvendelser deraf - Google Patents
Mikropartikler med adsorbent-overflader, fremgangsmåder til fremstilling af disse samt anvendelser derafInfo
- Publication number
- DK1100468T3 DK1100468T3 DK99937664T DK99937664T DK1100468T3 DK 1100468 T3 DK1100468 T3 DK 1100468T3 DK 99937664 T DK99937664 T DK 99937664T DK 99937664 T DK99937664 T DK 99937664T DK 1100468 T3 DK1100468 T3 DK 1100468T3
- Authority
- DK
- Denmark
- Prior art keywords
- microparticles
- applications
- processes
- preparation
- adsorbent surfaces
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12453398A | 1998-07-29 | 1998-07-29 | |
| US28585599A | 1999-04-02 | 1999-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1100468T3 true DK1100468T3 (da) | 2006-07-31 |
Family
ID=26822700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99937664T DK1100468T3 (da) | 1998-07-29 | 1999-07-29 | Mikropartikler med adsorbent-overflader, fremgangsmåder til fremstilling af disse samt anvendelser deraf |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1100468B1 (da) |
| JP (2) | JP4601168B2 (da) |
| AT (1) | ATE321535T1 (da) |
| AU (1) | AU763975B2 (da) |
| CA (1) | CA2338646C (da) |
| CY (1) | CY1107326T1 (da) |
| DE (1) | DE69930642T2 (da) |
| DK (1) | DK1100468T3 (da) |
| ES (1) | ES2260923T3 (da) |
| NZ (1) | NZ509853A (da) |
| PT (1) | PT1100468E (da) |
| WO (1) | WO2000006123A1 (da) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000050006A2 (en) | 1999-02-26 | 2000-08-31 | Chiron Corporation | Microemulsions with adsorbed macromoelecules and microparticles |
| US7713739B1 (en) | 2000-11-17 | 2010-05-11 | Novartis Vaccines And Diagnostics, Inc. | Microparticle-based transfection and activation of dendritic cells |
| WO2002000191A2 (de) * | 2000-06-29 | 2002-01-03 | Bernina Biosystems Gmbh | Bdellosomen |
| WO2002026212A2 (en) | 2000-09-28 | 2002-04-04 | Chiron Corporation | Microparticle compositions and methods for the manufacture thereof |
| US7838015B2 (en) * | 2001-10-03 | 2010-11-23 | Novartis Vaccines And Diagnostics, Inc. | Adjuvanted meningococcus compositions |
| AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
| NZ532274A (en) * | 2001-10-03 | 2006-02-24 | Chiron Corp | Adjuvanted meningococcus compositions |
| JP4646516B2 (ja) | 2002-02-20 | 2011-03-09 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 吸着したポリペプチド含有分子を有する微粒子 |
| WO2004032860A2 (en) | 2002-10-07 | 2004-04-22 | Chiron Corporation | Hiv vaccine formulations |
| EP2263687B1 (en) | 2002-12-27 | 2015-03-25 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions containing phospholipid |
| US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
| ES2596553T3 (es) | 2003-06-02 | 2017-01-10 | Glaxosmithkline Biologicals Sa | Composiciones inmunogénicas a base de micropartículas que comprenden toxoide adsorbido y un antígeno que contiene un polisacárido |
| FR2859909B1 (fr) | 2003-09-22 | 2007-09-07 | Biomerieux Sa | Procede de preparation de microparticules bioresorbables, microparticules obtenues et utilisation |
| US7899527B2 (en) * | 2004-05-13 | 2011-03-01 | Palo Alto Investors | Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase |
| WO2006050394A2 (en) | 2004-11-01 | 2006-05-11 | Novartis Vaccines And Diagnostics Inc. | Combination approaches for generating immune responses |
| AU2005334819B2 (en) | 2004-11-15 | 2011-11-24 | Novartis Vaccines And Diagnostics Inc. | Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
| US9393215B2 (en) | 2005-12-02 | 2016-07-19 | Novartis Ag | Nanoparticles for use in immunogenic compositions |
| US8431160B2 (en) | 2006-02-24 | 2013-04-30 | Novartis Ag | Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| AU2008335457B2 (en) | 2007-12-07 | 2015-04-16 | Glaxosmithkline Biologicals S.A. | Compositions for inducing immune responses |
| WO2009134769A1 (en) | 2008-04-28 | 2009-11-05 | Novartis Ag | Nanoparticles for use in pharmaceutical compositions |
| WO2010138193A2 (en) | 2009-05-27 | 2010-12-02 | Selecta Biosciences, Inc. | Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
| EP2525815B1 (en) * | 2010-01-24 | 2015-02-25 | Novartis AG | Irradiated biodegradable polymer microparticles |
| CN107029223A (zh) | 2010-05-26 | 2017-08-11 | 西莱克塔生物科技公司 | 合成纳米载体联合疫苗 |
| CN102933267B (zh) | 2010-05-28 | 2015-05-27 | 泰特里斯在线公司 | 交互式混合异步计算机游戏基础结构 |
| US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
| EP2640190A4 (en) | 2010-11-05 | 2016-05-11 | Selecta Biosciences Inc | MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS |
| US9636410B2 (en) | 2011-07-06 | 2017-05-02 | Glaxosmithkline Biologicals Sa | Cationic oil-in-water emulsions |
| US9655845B2 (en) | 2011-07-06 | 2017-05-23 | Glaxosmithkline Biologicals, S.A. | Oil-in-water emulsions that contain nucleic acids |
| JP2014521687A (ja) | 2011-07-29 | 2014-08-28 | セレクタ バイオサイエンシーズ インコーポレーテッド | 体液性および細胞傷害性tリンパ球(ctl)免疫応答を生成する合成ナノキャリア |
| EP2968510B1 (en) | 2013-03-14 | 2019-10-09 | President and Fellows of Harvard College | Nanoparticle-based compositions |
| KR20240163740A (ko) | 2022-03-30 | 2024-11-19 | 에보니크 오퍼레이션즈 게엠베하 | 세포 내로의 폴리뉴클레오티드의 전달을 위한 양이온성 지질 및 폴리(락틱-코-글리콜산)로 구성된 제제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE252894T1 (de) * | 1995-01-05 | 2003-11-15 | Univ Michigan | Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung |
| GB9514285D0 (en) * | 1995-07-13 | 1995-09-13 | Univ Nottingham | Polymeric lamellar substrate particles for drug delivery |
| US5759583A (en) * | 1995-08-30 | 1998-06-02 | Syntex (U.S.A.) Inc. | Sustained release poly (lactic/glycolic) matrices |
| ES2195317T3 (es) * | 1997-01-30 | 2003-12-01 | Chiron Corp | Uso de microparticulas con antigeno adsorbido para estimular respuestas inmunitarias. |
-
1999
- 1999-07-29 WO PCT/US1999/017308 patent/WO2000006123A1/en not_active Ceased
- 1999-07-29 PT PT99937664T patent/PT1100468E/pt unknown
- 1999-07-29 AU AU52452/99A patent/AU763975B2/en not_active Ceased
- 1999-07-29 CA CA002338646A patent/CA2338646C/en not_active Expired - Fee Related
- 1999-07-29 DE DE69930642T patent/DE69930642T2/de not_active Expired - Lifetime
- 1999-07-29 JP JP2000561979A patent/JP4601168B2/ja not_active Expired - Fee Related
- 1999-07-29 EP EP99937664A patent/EP1100468B1/en not_active Expired - Lifetime
- 1999-07-29 DK DK99937664T patent/DK1100468T3/da active
- 1999-07-29 ES ES99937664T patent/ES2260923T3/es not_active Expired - Lifetime
- 1999-07-29 AT AT99937664T patent/ATE321535T1/de active
- 1999-07-29 NZ NZ509853A patent/NZ509853A/en not_active IP Right Cessation
-
2006
- 2006-06-05 CY CY20061100736T patent/CY1107326T1/el unknown
-
2010
- 2010-03-15 JP JP2010058491A patent/JP2010168392A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1100468A1 (en) | 2001-05-23 |
| CY1107326T1 (el) | 2012-11-21 |
| WO2000006123A1 (en) | 2000-02-10 |
| DE69930642D1 (de) | 2006-05-18 |
| NZ509853A (en) | 2003-08-29 |
| EP1100468B1 (en) | 2006-03-29 |
| JP4601168B2 (ja) | 2010-12-22 |
| AU5245299A (en) | 2000-02-21 |
| JP2010168392A (ja) | 2010-08-05 |
| AU763975B2 (en) | 2003-08-07 |
| HK1035862A1 (en) | 2001-12-14 |
| PT1100468E (pt) | 2006-07-31 |
| ES2260923T3 (es) | 2006-11-01 |
| DE69930642T2 (de) | 2006-12-28 |
| ATE321535T1 (de) | 2006-04-15 |
| CA2338646A1 (en) | 2000-02-10 |
| JP2002521425A (ja) | 2002-07-16 |
| CA2338646C (en) | 2008-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1100468E (pt) | Microparticulas com superficies adsorventes, processos de fabrico e utilizacao das mesmas | |
| WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
| NZ508366A (en) | Neisseria meningitidis antigens and compositions | |
| WO2001075067A8 (en) | Novel nucleic acids and polypeptides | |
| WO2001057188A3 (en) | Novel nucleic acids and polypeptides | |
| WO2002022660A3 (en) | Novel nucleic acids and polypeptides | |
| WO2001066689A3 (en) | Novel nucleic acids and polypeptides | |
| WO2002031111A3 (en) | Novel nucleic acids and polypeptides | |
| WO2003023013A3 (en) | Novel nucleic acids and polypeptides | |
| WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
| ATE394484T1 (de) | Smad 6 und dessen anwendungen | |
| ATE297190T1 (de) | Mikroemulsionen mit adsorbierten makromolekülen und mikropartikeln | |
| WO2003029271A3 (en) | Novel nucleic acids and polypeptides | |
| WO2002042422A3 (en) | Molecular interactions in hematopoietic cells | |
| WO2002062957A3 (en) | Ter sites and ter binding proteins | |
| WO2002018424A3 (en) | Nucleic acids and polypeptides | |
| WO2001079449A3 (en) | Novel nucleic acids and polypeptides | |
| ATE389881T1 (de) | Detektion von kleinen molekülen mit piezo- elektrischem sensor | |
| WO2000070353A3 (en) | High throughput assay systems and methods | |
| DE60034885D1 (de) | Enzymlauge und verfahren zu deren herstellung, enzymzubereitung, proteasezubereitungen und proteaseproduzierendes bakterium | |
| DE50210176D1 (de) | Stickstoffhaltige polymere umfassende reinigungsmittelzusammensetzung | |
| AU2002368411A1 (en) | Method for immobilizing biologic molecules on solid surfaces | |
| WO2002044340A3 (en) | Novel nucleic acids and polypeptides | |
| WO2001019970A3 (en) | Chymotrypsin-free trypsin | |
| WO2002031512A3 (en) | Molecular interactions in hematopoietic cells |